Kindstar (康圣环球) IPO Trading: Pattern of Demand Divergence
We look at the updates on Kindstar IPO since our last note. With its valuation higher than leading ICL peer, we do not expect a strong debut...
285 Views
Brii Biosciences (腾盛博药) IPO Trading: Note the Pre-IPO Investors Subscription
We look at the updates since our last note for Brii. We note that the allocation to institutional investors were heavily concentrated in the...
330 Views
ECM Weekly (4th July 2021) - Xpeng, Medbot, Medlive, Brii Bio, CTOS, LinkDoc, Devyani, Manycore
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
447 Views
Brii Biosciences (腾盛博药) IPO: Not a Demanding Valuation for Its Differentiation
We provide an update for the book building of Brii IPO. We think the valuation of the deal is not demanding with upside for investors.
479 Views
Brii Biosciences (腾盛博药) Pre-IPO: Thoughts on Valuation
We provide our thoughts on the pre-money valuation for Brii Biosciences. We valued the BRII-179/BRII-835 for HBV and BRII-778/BRII-732 for HIV...
336 Views